Les données publiées sur Atalante X et Eve, et les documents qui les étayent
Clinical evidence
Rehabilitation with Atalante X may support patients' physical improvement — endurance, ambulatory capacities, balance and trunk postural control.1
Atalante X is safe to use for diverse populations and patients living with stroke and spinal cord injury.1
Patients who used Atalante X report extremely high satisfaction rates, up to 100%.1
Key takeaways, Benefits of Atalante X one-pager, December 2024
After a stroke
After 5 sessions of Atalante training patients had improved gait speed by 0.05 ± 0.08 m/s (p=0.002), improved endurance by 11.6 ± 18 meters (p=0.001), improved ambulatory capacities (FAC score) by 0.6 ± 1.0 point (p=0.002) and improved balance (BBS score) by 6.2 ± 8.1 points (p=0.0001).1
87% patients were satisfied with the program and would recommend it to other stroke patients.1 The peer-reviewed INSPIRE safety study reports the same program in full.2
INSPIRE — 31 patients, 6 centers. Results measured without the device.
What patients report
The level of satisfaction at the end of the program was 86%.1
Patients with paraplegia also reported improved sitting balance, psychological well-being and endurance.4
Post Market Clinical Follow-up Report — 18 patients, 16 centers
Tetraplegia and high paraplegia
We can conclude that the use of Atalante X exoskeleton is safe and feasible with this population.5
One adverse event in 547 Atalante sessions.6 The peer-reviewed retrospective adds: after individual benefit-risk assessment, the Atalante exoskeleton can be safely used in a clinical setting for high SCI patients.7
QUATRO — 33 patients with spinal cord injury, 3 centers
In intensive care
Physiotherapy using Atalante in the acute neurosurgery setting is safe and feasible. Staff organization is a key element of success.18
Average time of verticalization was 16 minutes, and 100% of patients were satisfied and expressed a desire to repeat exoskeleton sessions.1 ICU-acquired weakness is equivalent to 40% loss of muscle strength in one week of immobility.9
17 patients, 1 center. The newest area of use, and the smallest evidence base so far.
Outside a trial
Registry and program data from centers running Atalante X in ordinary clinical routine, rather than under study conditions.
patients across 34 rehabilitation centers in Europe and the United States, February 2021 to November 202310
steps walked in one year by more than 60 patients at a single rehabilitation institute11
of weekly sessions in ALERT, with sitting balance and walked distance both improved12
An exoskeleton is not there to replace the work of a physiotherapist, it's a tool that can be used to improve patients' outcome through a high-tech, innovative interaction between physiotherapists and patients.
13
Franco Molteni, Villa Beretta Rehabilitation Research Innovation Institute
Une véritable expertise humaine, à chaque pas.
Les exosquelettes de marche, comme Atalante X, sont des outils innovants dans la prise en charge des personnes avec déficience à la marche. Ils permettent de maximiser le travail de rééducation ; d’espérer améliorer la récupération après une lésion neurologique ; et de prévenir l’apparition de complications liées à la station assise.
